-

FoodScience, LLC Announces Acquisition of Natural Dog Company, Expanding Leadership in Pet Wellness

WILLISTON, Vt.--(BUSINESS WIRE)--FoodScience, LLC, a leading provider of premium health and wellness solutions for pets and people, today announced the acquisition of Natural Dog Company, a brand known for its high-quality dog care products. Founded in 2006 and based in North Carolina, Natural Dog Company has earned loyal customers through its dedication to effective solutions.

This marks the first acquisition for FoodScience since becoming a portfolio company of Morgan Stanley Capital Partners (MSCP) in November 2024.

“We believe Natural Dog Company is a strong strategic fit for FoodScience,” said James Stewart, Managing Director and Co-Head of Consumer Investing at MSCP. “This acquisition reflects our commitment to investing behind category-defining brands with loyal followings, differentiated products, and strong growth potential. We believe the combination of the Natural Dog brand and FoodScience’s operational excellence will accelerate growth and drive long-term value creation.”

Sharon Rossi, Chief Executive Officer of FoodScience, commented: “We are delighted to welcome Natural Dog Company to FoodScience. This acquisition represents an important step in our growth journey and expands our presence in pet wellness and supplements. Natural Dog brings a highly respected brand that aligns with our values and long-standing commitment to quality and innovation. Together, we’ll continue delivering trusted solutions for pets and the people who care for them.”

Bill D’Alessandro, CEO of Natural Dog Company, added: “We weren’t looking for just any buyer—we were looking for the right partner. FoodScience shares our obsession with product quality, our passion for pet wellness, and our belief in doing things the right way. They’ve built trust with customers for over 50 years and have deep expertise in areas that will help Natural Dog grow even stronger. I’m incredibly excited for what we are going to build together—and for all the good we’ll continue to do for dogs and their humans.”

Terms of the transaction were not disclosed.

About FoodScience, LLC
Based in Williston, Vermont, FoodScience, LLC is a leading developer, manufacturer, and marketer of health and wellness supplements for pets and humans. With more than 50 years of experience, the company is known for its product innovation, rigorous quality standards, and trusted brands including VetriScience®, Pet Naturals®, and DaVinci Labs®. www.foodsciencecorp.com

About Natural Dog Company
Founded in 2006, Natural Dog Company offers a portfolio of high-quality products designed to keep dogs healthy, happy, and active—from skin and coat solutions to supplements and grooming care. With a devoted customer base and a strong digital presence, the brand is known for its integrity, transparency, and love for dogs. www.naturaldog.com

About Morgan Stanley Capital Partners

Morgan Stanley Capital Partners, part of Morgan Stanley Investment Management, is a leading middle-market private equity platform established in 1986 that focuses on privately negotiated equity and equity-related investments primarily in North America. Morgan Stanley Capital Partners seeks to create value in portfolio companies primarily in a series of subsectors in the business and consumer, healthcare, and industrial services markets with an emphasis on driving significant organic and acquisition growth through an operationally focused approach. For further information about Morgan Stanley Capital Partners, please visit www.morganstanley.com/im/capitalpartners.

Contacts

Media:

Morgan Stanley: Alyson Barnes
alyson.barnes@morganstanley.com

FoodScience


Release Versions

Contacts

Media:

Morgan Stanley: Alyson Barnes
alyson.barnes@morganstanley.com

More News From FoodScience

Morgan Stanley Expansion Capital Leads $33 Million Growth Financing For Subtle Medical

NEW YORK--(BUSINESS WIRE)--Morgan Stanley Investment Management announced today that funds managed by Morgan Stanley Expansion Capital have led a $33 million growth financing for Subtle Medical (the Company), a medical imaging software company using artificial intelligence to improve imaging workflow efficiency and image quality across MRI, PET and CT. The financing included participation from Shinhan Venture Investment and existing investors Fusion Fund, EnvisionX, BRV, and Samsung Ventures, b...

Morgan Stanley Investment Management Introduces Wealth Education Center

BOSTON--(BUSINESS WIRE)--Morgan Stanley Investment Management (MSIM) today announced the launch of the Wealth Education Center, a centralized education platform designed to help financial advisors translate growing market, tax and investment complexity into clear, practical guidance for their clients. “Advisors face a growing challenge as financial markets, products and tax considerations become more interconnected,” said Ben Huneke, Head of Morgan Stanley Investment Management. “They have acce...

Morgan Stanley Investment Management Provides $875 Million Debt Financing to Bridgepointe Technologies

NEW YORK--(BUSINESS WIRE)--Morgan Stanley Investment Management announced today that funds managed by Morgan Stanley Private Credit have led an $875 million senior debt financing package for Bridgepointe Technologies (Bridgepointe or the Company), a leading technology advisory and enablement services platform. The debt financing was provided alongside the creation of a continuation vehicle led by Carlyle AlpInvest, alongside an equity investment from existing investor Charlesbank Capital Partne...
Back to Newsroom